230 related articles for article (PubMed ID: 9482899)
1. Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.
Zhou S; Buckhaults P; Zawel L; Bunz F; Riggins G; Dai JL; Kern SE; Kinzler KW; Vogelstein B
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2412-6. PubMed ID: 9482899
[TBL] [Abstract][Full Text] [Related]
2. DPC4 (SMAD4) mediates transforming growth factor-beta1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumour cells.
de Winter JP; Roelen BA; ten Dijke P; van der Burg B; van den Eijnden-van Raaij AJ
Oncogene; 1997 Apr; 14(16):1891-9. PubMed ID: 9150356
[TBL] [Abstract][Full Text] [Related]
3. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes.
Liu F; Pouponnot C; Massagué J
Genes Dev; 1997 Dec; 11(23):3157-67. PubMed ID: 9389648
[TBL] [Abstract][Full Text] [Related]
4. Cellular interpretation of multiple TGF-beta signals: intracellular antagonism between activin/BVg1 and BMP-2/4 signaling mediated by Smads.
Candia AF; Watabe T; Hawley SH; Onichtchouk D; Zhang Y; Derynck R; Niehrs C; Cho KW
Development; 1997 Nov; 124(22):4467-80. PubMed ID: 9409665
[TBL] [Abstract][Full Text] [Related]
5. Smad3 inhibits transforming growth factor-beta and activin signaling by competing with Smad4 for FAST-2 binding.
Nagarajan RP; Liu J; Chen Y
J Biol Chem; 1999 Oct; 274(44):31229-35. PubMed ID: 10531318
[TBL] [Abstract][Full Text] [Related]
6. Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling.
Sirard C; Kim S; Mirtsos C; Tadich P; Hoodless PA; Itié A; Maxson R; Wrana JL; Mak TW
J Biol Chem; 2000 Jan; 275(3):2063-70. PubMed ID: 10636910
[TBL] [Abstract][Full Text] [Related]
7. The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function.
Zhang Y; Musci T; Derynck R
Curr Biol; 1997 Apr; 7(4):270-6. PubMed ID: 9094310
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human FAST-1, a TGF beta and activin signal transducer.
Zhou S; Zawel L; Lengauer C; Kinzler KW; Vogelstein B
Mol Cell; 1998 Jul; 2(1):121-7. PubMed ID: 9702198
[TBL] [Abstract][Full Text] [Related]
9. The role of FAST-1 and Smads in transcriptional regulation by activin during early Xenopus embryogenesis.
Yeo CY; Chen X; Whitman M
J Biol Chem; 1999 Sep; 274(37):26584-90. PubMed ID: 10473623
[TBL] [Abstract][Full Text] [Related]
10. Molecular and functional consequences of Smad4 C-terminal missense mutations in colorectal tumour cells.
De Bosscher K; Hill CS; Nicolás FJ
Biochem J; 2004 Apr; 379(Pt 1):209-16. PubMed ID: 14715079
[TBL] [Abstract][Full Text] [Related]
11. Xenopus Smad4beta is the co-Smad component of developmentally regulated transcription factor complexes responsible for induction of early mesodermal genes.
Howell M; Itoh F; Pierreux CE; Valgeirsdottir S; Itoh S; ten Dijke P; Hill CS
Dev Biol; 1999 Oct; 214(2):354-69. PubMed ID: 10525340
[TBL] [Abstract][Full Text] [Related]
12. Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif.
Germain S; Howell M; Esslemont GM; Hill CS
Genes Dev; 2000 Feb; 14(4):435-51. PubMed ID: 10691736
[TBL] [Abstract][Full Text] [Related]
13. Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways.
Lagna G; Hata A; Hemmati-Brivanlou A; Massagué J
Nature; 1996 Oct; 383(6603):832-6. PubMed ID: 8893010
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
15. Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2.
Labbé E; Silvestri C; Hoodless PA; Wrana JL; Attisano L
Mol Cell; 1998 Jul; 2(1):109-20. PubMed ID: 9702197
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.
Chiao PJ; Hunt KK; Grau AM; Abramian A; Fleming J; Zhang W; Breslin T; Abbruzzese JL; Evans DB
Ann N Y Acad Sci; 1999 Jun; 880():31-7. PubMed ID: 10415848
[TBL] [Abstract][Full Text] [Related]
17. Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis.
Ramachandra M; Atencio I; Rahman A; Vaillancourt M; Zou A; Avanzini J; Wills K; Bookstein R; Shabram P
Cancer Res; 2002 Nov; 62(21):6045-51. PubMed ID: 12414627
[TBL] [Abstract][Full Text] [Related]
18. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.
Wang D; Kanuma T; Mizunuma H; Takama F; Ibuki Y; Wake N; Mogi A; Shitara Y; Takenoshita S
Cancer Res; 2000 Aug; 60(16):4507-12. PubMed ID: 10969799
[TBL] [Abstract][Full Text] [Related]
19. Characterization of functional domains within Smad4/DPC4.
de Caestecker MP; Hemmati P; Larisch-Bloch S; Ajmera R; Roberts AB; Lechleider RJ
J Biol Chem; 1997 May; 272(21):13690-6. PubMed ID: 9153220
[TBL] [Abstract][Full Text] [Related]
20. Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.
Montgomery E; Goggins M; Zhou S; Argani P; Wilentz R; Kaushal M; Booker S; Romans K; Bhargava P; Hruban R; Kern S
Am J Pathol; 2001 Feb; 158(2):537-42. PubMed ID: 11159190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
